Andrew Frederick Hemphill

Andrew Frederick Hemphill's AcademicInfluence.com Rankings

Chemistry

#5034

World Rank

#6138

Historical Rank

Organic Chemistry

#842

World Rank

#943

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Andrew Frederick Hemphill's Degrees

PhD Chemistry University of California, Berkeley
Bachelors Chemistry University of California, Berkeley

Why Is Andrew Frederick Hemphill Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Andrew Frederick Hemphill's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond (2016) (324)
Redescription of Neospora caninum and its differentiation from related coccidia. (2002) (181)
A European perspective on Neospora caninum. (2000) (177)
Survival of Trypanosoma brucei in the Tsetse Fly Is Enhanced by the Expression of Specific Forms of Procyclin (1997) (143)
The Trypanosoma brucei cAMP phosphodiesterases TbrPDEBl and TbrPDEB2: flagellar enzymes that are essential for parasite virulence (2007) (142)
Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections (2006) (136)
Neosporosis in Animals (2017) (135)
Adhesion and invasion of bovine endothelial cells by Neospora caninum (1996) (133)
Cellular and immunological basis of the host-parasite relationship during infection with Neospora caninum (2006) (118)
In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes. (2004) (116)
Treatment of echinococcosis: albendazole and mebendazole – what else? (2014) (112)
Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines (2003) (107)
Immunopathology of echinococcosis. (1997) (103)
In Vitro Parasiticidal Effect of Nitazoxanide against Echinococcus multilocularis Metacestodes (2003) (101)
In Vitro Metacestodicidal Activities of Genistein and Other Isoflavones against Echinococcus multilocularis and Echinococcus granulosus (2006) (100)
Comparison and standardisation of serological methods for the diagnosis of Neospora caninum infection in bovines. (2004) (98)
Identification of a major surface protein on Neospora caninum tachyzoites (1996) (97)
Novel amidines and analogues as promising agents against intracellular parasites: a systematic review (2013) (97)
Subcellular localization and functional characterization of Nc-p43, a major Neospora caninum tachyzoite surface protein (1996) (96)
The host-parasite relationship in neosporosis. (1999) (95)
Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity. (2004) (90)
Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole. (2007) (89)
In Vitro and In Vivo Treatments of Echinococcus Protoscoleces and Metacestodes with Artemisinin and Artemisinin Derivatives (2008) (89)
A Novel Giardia lamblia Nitroreductase, GlNR1, Interacts with Nitazoxanide and Other Thiazolides (2007) (88)
Efficacies of Albendazole Sulfoxide and Albendazole Sulfone against In Vitro-Cultivated Echinococcus multilocularis Metacestodes (1999) (87)
In Vitro Induction of Neospora caninum Bradyzoites in Vero Cells Reveals Differential Antigen Expression, Localization, and Host-Cell Recognition of Tachyzoites and Bradyzoites (2004) (86)
Characterization of a cDNA-clone encoding Nc-p43, a major Neospora caninum tachyzoite surface protein (1997) (85)
Thiazolides inhibit growth and induce glutathione‐S‐transferase Pi (GSTP1)‐dependent cell death in human colon cancer cells (2008) (84)
Alveolar and cystic echinococcosis: towards novel chemotherapeutical treatment options (2009) (82)
Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole. (2008) (81)
Isolation of Besnoitia besnoiti from infected cattle in Portugal. (2006) (81)
Efficacy of toltrazuril and ponazuril against experimental Neospora caninum infection in mice (2001) (80)
Mitochondrial tRNA Import in Toxoplasma gondii* (2004) (80)
A Novel Family of Serine/Threonine Kinases Participating in Spermiogenesis (1997) (80)
MAHRP2, an exported protein of Plasmodium falciparum, is an essential component of Maurer's cleft tethers (2010) (79)
In Vitro Effects of Thiazolides on Giardia lamblia WB Clone C6 Cultured Axenically and in Coculture with Caco2 Cells (2006) (78)
Peroxide Bond-Dependent Antiplasmodial Specificity of Artemisinin and OZ277 (RBx11160) (2007) (77)
Immunology and morphology studies on the proliferation of in vitro cultivatedEchinococcus multilocularis metacestodes (2004) (75)
Major Carbohydrate Antigen of Echinococcus multilocularis Induces an Immunoglobulin G Response Independent of αβ+ CD4+ T Cells (2001) (74)
REDUCED CEREBRAL INFECTION OF NEOSPORA CANINUM–INFECTED MICE AFTER VACCINATION WITH RECOMBINANT MICRONEME PROTEIN NCMIC3 AND RIBI ADJUVANT (2003) (74)
Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites. (2009) (73)
Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites. (2008) (72)
Large microtubule-associated protein of T. brucei has tandemly repeated, near-identical sequences. (1988) (71)
Cestode parasites: application of in vivo and in vitro models for studies on the host-parasite relationship. (2002) (71)
An interlaboratory comparison of immunohistochemistry and PCR methods for detection of Neospora caninum in bovine foetal tissues. (2004) (68)
Differential expression of cell surface- and dense granule-associated Neospora caninum proteins in tachyzoites and bradyzoites. (1998) (67)
Vaccines against neosporosis: what can we learn from the past studies? (2014) (66)
A review on bovine besnoitiosis: a disease with economic impact in herd health management, caused by Besnoitia besnoiti (Franco and Borges, 1916) (2014) (65)
Exogenous nitric oxide triggers Neospora caninum tachyzoite-to-bradyzoite stage conversion in murine epidermal keratinocyte cell cultures. (2002) (65)
Identification and partial characterization of a 36 kDa surface protein on Neospora caninum tachyzoites (1997) (64)
Identification and characterization of two repetitive non-variable antigens from African trypanosomes which are recognized early during infection (1992) (63)
Echinococcus metacestodes as laboratory models for the screening of drugs against cestodes and trematodes (2009) (63)
Neospora caninum Calcium-Dependent Protein Kinase 1 Is an Effective Drug Target for Neosporosis Therapy (2014) (63)
Identification of a Neospora caninum Microneme Protein (NcMIC1) Which Interacts with Sulfated Host Cell Surface Glycosaminoglycans (2002) (62)
Electron microscopy in parasitology. (1997) (61)
Application of Real-Time Fluorescent PCR for Quantitative Assessment of Neospora caninum Infections in Organotypic Slice Cultures of Rat Central Nervous System Tissue (2002) (60)
In Vitro and In Vivo Efficacies of Mefloquine-Based Treatment against Alveolar Echinococcosis (2010) (60)
Stage-specific expression of the 14-3-3 gene in Echinococcus multilocularis. (1998) (60)
Host insulin stimulates Echinococcus multilocularis insulin signalling pathways and larval development (2014) (60)
In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum (2015) (60)
REDUCED INFECTION AND PROTECTION FROM CLINICAL SIGNS OF CEREBRAL NEOSPOROSIS IN C57BL/6 MICE VACCINATED WITH RECOMBINANT MICRONEME ANTIGEN NCMIC1 (2005) (60)
In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes. (2008) (59)
Intestinal Tritrichomonas foetus infection in cats in Switzerland detected by in vitro cultivation and PCR (2009) (56)
Isolation and Characterization of a Secretory Component of Echinococcus multilocularis Metacestodes Potentially Involved in Modulating the Host-Parasite Interface (2004) (56)
Neospora caninum Microneme Protein NcMIC3: Secretion, Subcellular Localization, and Functional Involvement in Host Cell Interaction (2001) (55)
The cytoskeletal architecture of Trypanosoma brucei. (1991) (55)
Echinococcus multilocularis: the parasite-host interplay. (2008) (54)
A novel microtubule-binding motif identified in a high molecular weight microtubule-associated protein from Trypanosoma brucei (1992) (54)
Neospora caninum: functional inhibition of protein disulfide isomerase by the broad-spectrum anti-parasitic drug nitazoxanide and other thiazolides. (2008) (54)
Neospora caninum protein disulfide isomerase is involved in tachyzoite-host cell interaction. (2005) (53)
Phosphorylation of a major GPI-anchored surface protein of Trypanosoma brucei during transport to the plasma membrane. (1999) (53)
Temporal dissection of Bax‐induced events leading to fission of the single mitochondrion in Trypanosoma brucei (2004) (53)
The Cytoskeleton of trypanosomes. (1990) (53)
Prophylactic and therapeutic efficacy of nitazoxanide against Cryptosporidium parvum in experimentally challenged neonatal calves (2008) (52)
Molecular characterization of a novel microneme antigen in Neospora caninum. (2000) (52)
Major Surface Glycoproteins of Insect Forms of Trypanosoma brucei Are Not Essential for Cyclical Transmission by Tsetse (2009) (52)
Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes. (2010) (51)
Innovative chemotherapeutical treatment options for alveolar and cystic echinococcosis (2007) (51)
Neospora caninum and Toxoplasma gondii: a novel adhesion/invasion assay reveals distinct differences in tachyzoite-host cell interactions. (2003) (51)
Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites (2009) (51)
Intraperitoneal Echinococcus multilocularis infection in mice modulates peritoneal CD4+ and CD8+ regulatory T cell development. (2011) (50)
In Vitro Efficacies of Nitazoxanide and Other Thiazolides against Neospora caninum Tachyzoites Reveal Antiparasitic Activity Independent of the Nitro Group (2005) (50)
Identification and characterisation of a dense granule-associated protein in Neospora caninum tachyzoites. (1998) (50)
Vaccination of mice with chitosan nanogel‐associated recombinant NcPDI against challenge infection with Neospora caninum tachyzoites (2011) (50)
Vero cell surface proteoglycan interaction with the microneme protein NcMIC(3) mediates adhesion of Neospora caninum tachyzoites to host cells unlike that in Toxoplasma gondii. (2002) (48)
In vitro culture systems for the study of apicomplexan parasites in farm animals. (2013) (48)
The major 36 kDa Neospora caninum tachyzoite surface protein is closely related to the major Toxoplasma gondii surface antigen. (1998) (47)
An intact laminated layer is important for the establishment of secondary Echinococcus multilocularis infection (2002) (47)
Culture of Echinococcus multilocularis metacestodes: an alternative to animal use. (2002) (46)
Extended-spectrum antiprotozoal bumped kinase inhibitors: A review. (2017) (45)
Susceptibility versus resistance in alveolar echinococcosis (larval infection with Echinococcus multilocularis). (2015) (44)
New approaches for the identification of drug targets in protozoan parasites. (2013) (43)
Tissue Culture and Explant Approaches to Studying and Visualizing Neospora caninum and Its Interactions with the Host Cell (2004) (43)
Application of conventional and real-time fluorescent ITS1 rDNA PCR for detection of Besnoitia besnoiti infections in bovine skin biopsies. (2007) (42)
Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice (2015) (41)
The antigenic composition of Neospora caninum. (1999) (41)
The Trypanosoma brucei cytoskeleton: ultrastructure and localization of microtubule-associated and spectrin-like proteins using quick-freeze, deep-etch, immunogold electron microscopy. (1991) (40)
Host Cells Participate in the In Vitro Effects of Novel Diamidine Analogues against Tachyzoites of the Intracellular Apicomplexan Parasites Neospora caninum and Toxoplasma gondii (2008) (40)
Vaccines for bovine neosporosis: current status and key aspects for development (2016) (40)
The interaction of Trypanosoma congolense with endothelial cells (1994) (40)
Vaccines against a Major Cause of Abortion in Cattle, Neospora caninum Infection (2011) (40)
Approaches for the vaccination and treatment of Neospora caninum infections in mice and ruminant models (2015) (40)
Inhibitory Effect of Aureobasidin A on Toxoplasma gondii (2005) (40)
A new promising application for highly cytotoxic metal compounds: η6-areneruthenium(II) phosphite complexes for the treatment of alveolar echinococcosis. (2012) (39)
Thioureides of 2-(phenoxymethyl)benzoic acid 4-R substituted: a novel class of anti-parasitic compounds. (2009) (39)
Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice (2015) (39)
Influence of the gestational stage on the clinical course, lesional development and parasite distribution in experimental ovine neosporosis (2015) (39)
High molecular mass glycans are major structural elements associated with the laminated layer of in vitro cultivated Echinococcus multilocularis metacestodes. (2000) (39)
A repetitive protein from Trypanosoma brucei which caps the microtubules at the posterior end of the cytoskeleton. (1993) (38)
Induction of tachyzoite egress from cells infected with the protozoan Neospora caninum by nitro- and bromo-thiazolides, a class of broad-spectrum anti-parasitic drugs. (2007) (38)
Echinococcus multilocularis Alkaline Phosphatase as a Marker for Metacestode Damage Induced by In Vitro Drug Treatment with Albendazole Sulfoxide and Albendazole Sulfone (2001) (38)
In vitro efficacy of nitro- and bromo-thiazolyl-salicylamide compounds (thiazolides) against Besnoitia besnoiti infection in Vero cells (2007) (37)
Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection. (2018) (37)
Major carbohydrate antigen of Echinococcus multilocularis induces an immunoglobulin G response independent of alphabeta+ CD4+ T cells. (2001) (37)
Molecular survival strategies of Echinococcus multilocularis in the murine host. (2006) (36)
Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice. (2012) (36)
Structure-activity relationships from in vitro efficacies of the thiazolide series against the intracellular apicomplexan protozoan Neospora caninum. (2007) (36)
Repetitive proteins from the flagellar cytoskeleton of African trypanosomes are diagnostically useful antigens (1995) (36)
Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis (2017) (36)
In Vitro Efficacy of Dicationic Compounds and Mefloquine Enantiomers against Echinococcus multilocularis Metacestodes (2011) (35)
Drug target identification in protozoan parasites (2016) (35)
Molecular characterisation of BSR4, a novel bradyzoite-specific gene from Neospora caninum. (2007) (35)
Experimental treatment of Neospora caninum-infected mice with the arylimidamide DB750 and the thiazolide nitazoxanide. (2011) (35)
Flagellum-mediated adhesion ofTrypanosoma congolense to bovine aorta endothelial cells (2004) (34)
Systemic and local immune responses in sheep after Neospora caninum experimental infection at early, mid and late gestation (2016) (34)
Identification and Characterization of a Neospora caninum Microneme-Associated Protein (NcMIC4) That Exhibits Unique Lactose-Binding Properties (2004) (34)
VACCINATION WITH MICRONEME PROTEIN NCMIC4 INCREASES MORTALITY IN MICE INOCULATED WITH NEOSPORA CANINUM (2007) (34)
Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis (2016) (34)
RecNcMIC3-1-R is a microneme- and rhoptry-based chimeric antigen that protects against acute neosporosis and limits cerebral parasite load in the mouse model for Neospora caninum infection. (2011) (34)
Comparative Pathobiology of the Intestinal Protozoan Parasites Giardia lamblia, Entamoeba histolytica, and Cryptosporidium parvum (2019) (33)
Amino ozonides exhibit in vitro activity against Echinococcus multilocularis metacestodes. (2014) (33)
14-3-3- and II/3-10-gene expression as molecular markers to address viability and growth activity of Echinococcus multilocularis metacestodes (2005) (33)
Voluntary ingestion of antiparasitic drugs emulsified in honey represents an alternative to gavage in mice. (2012) (33)
Triggering and modulation of the host-parasite interplay by Echinococcus multilocularis: a review (2009) (32)
Profound Activity of the Anti-cancer Drug Bortezomib against Echinococcus multilocularis Metacestodes Identifies the Proteasome as a Novel Drug Target for Cestodes (2014) (32)
In Vitro Effects of Novel Ruthenium Complexes in Neospora caninum and Toxoplasma gondii Tachyzoites (2013) (32)
Neospora caninum in non-pregnant and pregnant mouse models: cross-talk between infection and immunity. (2017) (32)
Toltrazuril treatment of congenitally acquired Neospora caninum infection in newborn mice (2009) (31)
Proteins mediating the Neospora caninum-host cell interaction as targets for vaccination. (2013) (31)
A live vaccine against Neospora caninum abortions in cattle. (2015) (30)
Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis (2018) (30)
Physiological aspects of nitro drug resistance in Giardia lamblia (2018) (29)
Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned. (2020) (29)
The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis (2019) (29)
Trypanosoma brucei RRM1 Is a Nuclear RNA-Binding Protein and Modulator of Chromatin Structure (2015) (29)
Echinococcus multilocularis phosphoglucose isomerase (EmPGI): a glycolytic enzyme involved in metacestode growth and parasite-host cell interactions. (2010) (29)
Elaboration of a crude antigen ELISA for serodiagnosis of caprine neosporosis: validation of the test by detection of Neospora caninum-specific antibodies in goats from Sri Lanka. (2004) (29)
Echinococcus P29 Antigen: Molecular Characterization and Implication on Post-Surgery Follow-Up of CE Patients Infected with Different Species of the Echinococcus granulosus Complex (2014) (29)
Virulence in Mice of a Toxoplasma gondii Type II Isolate Does Not Correlate With the Outcome of Experimental Infection in Pregnant Sheep (2019) (28)
Oral treatments of Echinococcus multilocularis-infected mice with the antimalarial drug mefloquine that potentially interacts with parasite ferritin and cystatin. (2015) (28)
The adaptive potential of a survival artist: characterization of the in vitro interactions of Toxoplasma gondii tachyzoites with di-cationic compounds in human fibroblast cell cultures (2011) (28)
Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis (2018) (28)
Activities of fenbendazole in comparison with albendazole against Echinococcus multilocularis metacestodes in vitro and in a murine infection model. (2014) (28)
Dose-dependent effects of experimental infection with the virulent Neospora caninum Nc-Spain7 isolate in a pregnant mouse model. (2015) (28)
Thiazolide-induced apoptosis in colorectal cancer cells is mediated via the Jun kinase–Bim axis and reveals glutathione-S-transferase P1 as Achilles’ heel (2012) (27)
In vitro screening of the open source Pathogen Box identifies novel compounds with profound activities against Neospora caninum. (2017) (27)
Antimicrobial effects of murine mesenchymal stromal cells directed against Toxoplasma gondii and Neospora caninum: role of immunity-related GTPases (IRGs) and guanylate-binding proteins (GBPs) (2013) (26)
Characterization of the Activities of Dinuclear Thiolato-Bridged Arene Ruthenium Complexes against Toxoplasma gondii (2017) (26)
Electron microscopical investigation of surface alterations on Giardia lamblia trophozoites after exposure to a cytotoxic monoclonal antibody (1996) (26)
A chicken anti-conoid monoclonal antibody identifies a common epitope which is present on motile stages of Eimeria, Neospora, and Toxoplasma. (1998) (25)
Echinococcus multilocularis metacestodes: immunological and immunocytochemical analysis of the relationships between alkaline phosphatase and the Em2 antigen. (1997) (25)
DIFFERENTIAL EFFECTS OF INTERFERON-γ AND TUMOR NECROSIS FACTOR-α ON TOXOPLASMA GONDII PROLIFERATION IN ORGANOTYPIC RAT BRAIN SLICE CULTURES (2005) (24)
The repetitive microtubule-associated proteins MARP-1 and MARP-2 of Trypanosoma brucei. (1994) (24)
Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis. (2017) (24)
In vitro culture of Echinococcus multilocularis and Echinococcus vogeli metacestodes: studies on the host-parasite interface. (2003) (24)
Experimental Infections of Neonatal Mice with Cysts of Giardia lamblia Clone GS/M-83-H7 Are Associated with an Antigenic Reset of the Parasite (2004) (24)
Two Novel Calcium-Dependent Protein Kinase 1 Inhibitors Interfere with Vertical Transmission in Mice Infected with Neospora caninum Tachyzoites (2017) (23)
A vaccine formulation combining rhoptry proteins NcROP40 and NcROP2 improves pup survival in a pregnant mouse model of neosporosis. (2015) (23)
Phenotypic and molecular characterization of hyperpigmented group B Streptococci. (2014) (23)
Identification of novel rhoptry proteins in Neospora caninum by LC/MS-MS analysis of subcellular fractions. (2011) (23)
Identification of a host cell target for the thiazolide class of broad-spectrum anti-parasitic drugs. (2011) (23)
Accessible and distinct decoquinate derivatives active against Mycobacterium tuberculosis and apicomplexan parasites (2018) (23)
The Trypanosoma brucei autoantigen I/6 is an internally repetitive cytoskeletal protein. (1997) (23)
NcGRA2 as a molecular target to assess the parasiticidal activity of toltrazuril against Neospora caninum (2008) (23)
Infection of organotypic slice cultures from rat central nervous tissue with Neospora caninum: an alternative approach to study host-parasite interactions. (2002) (23)
Effects of miltefosine treatment in fibroblast cell cultures and in mice experimentally infected with Neospora caninum tachyzoites (2012) (22)
CHARACTERIZATION OF THE LAMINATED LAYER OF IN VITRO CULTIVATED ECHINOCOCCUS VOGELI METACESTODES (2001) (22)
Establishment and characterization of a primary canine duodenal epithelial cell culture (2007) (22)
In vitro effects of new artemisinin derivatives in Neospora caninum-infected human fibroblasts. (2015) (22)
Nucleoside diphosphate kinase of Trypanosoma brucei. (2000) (22)
Targeting of the mitochondrion by dinuclear thiolato-bridged arene ruthenium complexes in cancer cells and in the apicomplexan parasite Neospora caninum. (2019) (22)
Identification of a laminated layer-associated protein in Echinococcus multilocularis metacestodes (1998) (22)
PERFORMANCE OF A WESTERN IMMUNOBLOT ASSAY TO DETECT SPECIFIC ANTI-TOXOPLASMA GONDII IGG ANTIBODIES IN HUMAN SALIVA (2005) (22)
Characterization of a Giardia lamblia WB C6 clone resistant to the isoflavone formononetin. (2007) (21)
Comparative molecular investigation of Nc5-PCR amplicons from Neospora caninum NC-1 and Hammondia heydorni-Berlin-1996 (2001) (21)
Drug target identification in intracellular and extracellular protozoan parasites. (2011) (21)
Flagellar membrane fusion and protein exchange in trypanosomes; a new form of cell-cell communication? (2016) (21)
In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoites. (2017) (20)
Detection of surface-associated and intracellular glycoconjugates and glycoproteins in Neospora caninum tachyzoites. (1999) (20)
Subcutaneous Infection Model Facilitates Treatment Assessment of Secondary Alveolar Echinococcosis in Mice (2013) (20)
In vitro effects of arylimidamides against Besnoitia besnoiti infection in Vero cells (2011) (20)
Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds (2017) (20)
In vitro activity of gentamicin as an adjunct to penicillin against biofilm group B Streptococcus (2017) (20)
In Vitro and In Vivo Activities of Dicationic Diguanidino Compounds against Echinococcus multilocularis Metacestodes (2013) (20)
Repurposing of antiparasitic drugs: the hydroxy-naphthoquinone buparvaquone inhibits vertical transmission in the pregnant neosporosis mouse model (2016) (19)
Secretion of the novel Trichinella protein TSJ5 by T. spiralis and T. pseudospiralis muscle larvae. (2001) (19)
Differential effects of interferon-gamma and tumor necrosis factor-alpha on Toxoplasma gondii proliferation in organotypic rat brain slice cultures. (2005) (19)
Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites (2018) (19)
Stable expression of Escherichia coli beta-glucuronidase A (GusA) in Giardia lamblia: application to high-throughput drug susceptibility testing. (2009) (19)
Gene expression profiling in anti-CD11d mAb-treated spinal cord-injured rats (2009) (18)
Molecular cloning and characterization of NcROP2Fam-1, a member of the ROP2 family of rhoptry proteins in Neospora caninum that is targeted by antibodies neutralizing host cell invasion in vitro (2013) (18)
Neospora caninum and bone marrow‐derived dendritic cells: parasite survival, proliferation, and induction of cytokine expression (2009) (18)
Prevention and Immunotherapy of Secondary Murine Alveolar Echinococcosis Employing Recombinant EmP29 Antigen (2015) (18)
General strategies for efficient adjuvant incorporation of recombinant subunit immunogens. (2005) (18)
Quantitative assessment of sense and antisense transcripts from genes involved in antigenic variation (vsp genes) and encystation (cwp 1 gene) of Giardia lamblia clone GS/M-83-H7 (2004) (17)
N-terminal fusion of a toll-like receptor 2-ligand to a Neospora caninum chimeric antigen efficiently modifies the properties of the specific immune response (2016) (17)
Molecular characterization of Neospora caninum MAG1, a dense granule protein secreted into the parasitophorous vacuole, and associated with the cyst wall and the cyst matrix (2010) (17)
In Vitro Screening of the Open-Source Medicines for Malaria Venture Malaria Box Reveals Novel Compounds with Profound Activities against Theileria annulata Schizonts (2016) (16)
Differential effects of intranasal vaccination with recombinant NcPDI in different mouse models of Neospora caninum infection (2013) (16)
Immunization with a cocktail of antigens fused with OprI reduces Neospora caninum vertical transmission and postnatal mortality in mice. (2019) (16)
Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy (2019) (16)
Characterization of the Neospora caninum NcROP40 and NcROP2Fam-1 rhoptry proteins during the tachyzoite lytic cycle (2015) (16)
To see or not to see: non-invasive imaging for improved readout of drug treatment trials in the murine model of secondary alveolar echinococcosis (2017) (15)
A quantitative reverse-transcriptase PCR assay for the assessment of drug activities against intracellular Theileria annulata schizonts (2014) (15)
Elucidating the influence of praziquantel nanosuspensions on the in vivo metabolism of Taenia crassiceps cysticerci. (2016) (15)
Campylobacter portucalensis sp. nov., a new species of Campylobacter isolated from the preputial mucosa of bulls (2020) (15)
Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection. (2012) (15)
The single cyclic nucleotide-specific phosphodiesterase of the intestinal parasite Giardia lamblia represents a potential drug target (2017) (15)
Neospora caninum (2022) (14)
Thiazolides, a Novel Class of Anti-Infective Drugs, Effective Against Viruses, Bacteria, Intracellular and Extracellular Protozoan Parasites and Proliferating Mammalian Cells (2012) (14)
Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis (2020) (14)
Apicomplexans pulling the strings: manipulation of the host cell cytoskeleton dynamics (2016) (13)
Differential Effects on Survival, Humoral Immune Responses and Brain Lesions in Inbred BALB/C, CBA/CA, and C57BL/6 Mice Experimentally Infected with Neospora caninum Tachyzoites (2013) (13)
Activities of 11‐Azaartemisinin and N‐Sulfonyl Derivatives against Neospora caninum and Comparative Cytotoxicities (2017) (13)
Anti-parasitic dinuclear thiolato-bridged arene ruthenium complexes alter the mitochondrial ultrastructure and membrane potential in Trypanosoma brucei bloodstream forms. (2019) (13)
The tandemly repeated NTPase (NTPDase) from Neospora caninum is a canonical dense granule protein whose RNA expression, protein secretion and phosphorylation coincides with the tachyzoite egress (2016) (13)
Besnoitia besnoiti protein disulfide isomerase (BbPDI): molecular characterization, expression and in silico modelling. (2011) (13)
First Characterization of the Neospora caninum Dense Granule Protein GRA9 (2017) (12)
Structure-Function Relationship of Thiazolides, a Novel Class of Anti- Parasitic Drugs, Investigated in Intracellular and Extracellular Protozoan Parasites and Larval-Stage Cestodes (2007) (12)
Repurposing of commercially available anti-coccidials identifies diclazuril and decoquinate as potential therapeutic candidates against Besnoitia besnoiti infection. (2018) (12)
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases. (2020) (12)
Drugs Against Echinococcosis (2004) (12)
Echinococcus multilocularis: the impact of ionizing radiation on metacestodes. (2011) (12)
Use of a Th1 Stimulator Adjuvant for Vaccination against Neospora caninum Infection in the Pregnant Mouse Model (2013) (11)
Cardiolipin depletion‐induced changes in the Trypanosoma brucei proteome (2019) (11)
Decreased infarct size after focal cerebral ischemia in mice chronically infected with Toxoplasma gondii (2007) (11)
TbLpn, a key enzyme in lipid droplet formation and phospholipid metabolism, is essential for mitochondrial integrity and growth of Trypanosoma brucei (2018) (11)
The quest of the best - A SAR study of trithiolato-bridged dinuclear Ruthenium(II)-Arene compounds presenting antiparasitic properties. (2021) (11)
Special issue: Experimental studies in echinococcosis. (2008) (11)
Activity of Thymus capitatus essential oil components against in vitro cultured Echinococcus multilocularis metacestodes and germinal layer cells (2019) (11)
Evaluation of kinase-inhibitors nilotinib and everolimus against alveolar echinococcosis in vitro and in a mouse model. (2018) (11)
Neospora caninum and neosporosis — recent achievements in host and parasite cell biology and treatment (2006) (11)
Advances in the treatment, diagnosis, control and scientific understanding of taeniid cestode parasite infections over the past 50 years. (2021) (11)
Endochin-Like Quinolones Exhibit Promising Efficacy Against Neospora Caninum in vitro and in Experimentally Infected Pregnant Mice (2018) (11)
In vitro treatment of Besnoitia besnoiti with the naphto-quinone buparvaquone results in marked inhibition of tachyzoite proliferation, mitochondrial alterations and rapid adaptation of tachyzoites to increased drug concentrations (2018) (10)
Coumarin‐Tagged Dinuclear Trithiolato‐Bridged Ruthenium(II)⋅Arene Complexes: Photophysical Properties and Antiparasitic Activity (2020) (10)
Infection of Primary Canine Duodenal Epithelial Cell Cultures with Neospora caninum (2009) (10)
Neospora caninum: Structure and Fate of Multinucleated Complexes Induced by the Bumped Kinase Inhibitor BKI-1294 (2020) (10)
Applying biotin–streptavidin binding for iscom (immunostimulating complex) association of recombinant immunogens (2005) (10)
Depletion of cardiolipin induces major changes in energy metabolism in Trypanosoma brucei bloodstream forms (2020) (10)
Cellular and Molecular Targets of Nucleotide-Tagged Trithiolato-Bridged Arene Ruthenium Complexes in the Protozoan Parasites Toxoplasma gondii and Trypanosoma brucei (2021) (10)
Conjugates Containing Two and Three Trithiolato-Bridged Dinuclear Ruthenium(II)-Arene Units as In Vitro Antiparasitic and Anticancer Agents (2020) (10)
Mitochondrial sphingosine-1-phosphate lyase is essential for phosphatidylethanolamine synthesis and survival of Trypanosoma brucei (2020) (9)
Regulation of hepatic microRNAs in response to early stage Echinococcus multilocularis egg infection in C57BL/6 mice (2019) (9)
Neospora caninum: Differential Proteome of Multinucleated Complexes Induced by the Bumped Kinase Inhibitor BKI-1294 (2020) (9)
In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts (2021) (9)
Bumped kinase inhibitor 1369 is effective against Cystoisospora suis in vivo and in vitro (2019) (9)
Activities of Endochin-Like Quinolones Against in vitro Cultured Besnoitia besnoiti Tachyzoites (2020) (9)
Development of a high- versus low-pathogenicity model of the free-living amoeba Naegleria fowleri. (2012) (9)
MONOCLONAL ANTIBODY DIRECTED AGAINST NEOSPORA CANINUM TACHYZOITE CARBOHYDRATE EPITOPE REACTS SPECIFICALLY WITH APICAL COMPLEX–ASSOCIATED SIALYLATED BETA TUBULIN (2006) (8)
Safety of a Novel Listeria monocytogenes-Based Vaccine Vector Expressing NcSAG1 (Neospora caninum Surface Antigen 1) (2021) (8)
[The significance of cryptosporidiosis for the health of calves in Switzerland]. (2018) (7)
Recruitment of Host Nuclear Pore Components to the Vicinity of Theileria Schizonts (2020) (6)
Development and applications of cestode and trematode laboratory models (2010) (6)
The Impact of BKI-1294 Therapy in Mice Infected With the Apicomplexan Parasite Neospora caninum and Re-infected During Pregnancy (2020) (6)
Modulation of cis- and trans- Golgi and the Rab9A-GTPase during infection by Besnoitia besnoiti, Toxoplasma gondii and Neospora caninum. (2018) (6)
Incorporation of the Tat cell‐penetrating peptide into nanofibers improves the respective antitumor immune response (2020) (6)
Assessment of the Activity of Decoquinate and Its Quinoline-O-Carbamate Derivatives against Toxoplasma gondii In Vitro and in Pregnant Mice Infected with T. gondii Oocysts (2021) (5)
Fatty acid and retinol-binding protein: A novel antigen for immunodiagnosis of human strongyloidiasis (2019) (5)
Synthesis and Antiparasitic Activity of New Conjugates—Organic Drugs Tethered to Trithiolato-Bridged Dinuclear Ruthenium(II)–Arene Complexes (2021) (5)
Treatment of giardiasis and drug resistance (2011) (5)
Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice (2020) (5)
Synthesis, characterization and antiparasitic activity of organometallic derivatives of the anthelmintic drug albendazole. (2020) (5)
Endochin-like quinolones (ELQs) and bumped kinase inhibitors (BKIs): Synergistic and additive effects of combined treatments against Neospora caninum infection in vitro and in vivo (2021) (5)
Case report: Intestinal perforation and secondary peritonitis due to Acanthocephala infection in a black-bellied pangolin (Phataginus tetradactyla). (2020) (5)
Synthesis, Photophysical Properties and Biological Evaluation of New Conjugates BODIPY: Dinuclear Trithiolato‐Bridged Ruthenium(II)‐Arene Complexes (2022) (4)
Antiprotozoal Structure–Activity Relationships of Synthetic Leucinostatin Derivatives and Elucidation of their Mode of Action (2021) (4)
Development and characterization of monoclonal antibodies against Besnoitia besnoiti tachyzoites (2018) (4)
Intra-cisternal vaccination induces high-level protection against Neospora caninum infection in mice. (2012) (4)
Efficacy of novel albendazole salt formulations against secondary cystic echinococcosis in experimentally infected mice (2020) (4)
Conservation of calnexin in the early branching protozoan Tritrichomonas suis. (2000) (3)
Neosporosis in Miscellaneous Animals (2017) (3)
In Vitro Activities of MMV Malaria Box Compounds against the Apicomplexan Parasite Neospora caninum, the Causative Agent of Neosporosis in Animals (2020) (3)
Isolation of Human Small Extracellular Vesicles and Tracking of Their Uptake by Retinal Pigment Epithelial Cells In Vitro (2020) (3)
NcGRA2-RT-PCR to Detect Live Versus Dead Parasites in Neospora caninum-Infected Mice (2008) (3)
N. hughesi and Neosporosis in Horses and Other Equids (2017) (3)
Characterization of the fetuin-binding fraction of Neospora caninum tachyzoites and its potential involvement in host-parasite interactions (2007) (3)
Localization of a 56-kDa Antigen That is Present in Multiple Developmental Stages of Neospora caninum (2004) (3)
Marine Fishes Collected from Inland Streams of Alabama (1960) (3)
Differential Affinity Chromatography Coupled to Mass Spectrometry: A Suitable Tool to Identify Common Binding Proteins of a Broad-Range Antimicrobial Peptide Derived from Leucinostatin (2022) (3)
Vaccines and drugs against Neospora caninum, an important apicomplexan causing abortion in cattle and other farm animals [Corrigendum] (2015) (2)
Trueperella pecoris sp. nov. isolated from bovine and porcine specimens. (2021) (2)
Generation of parasite cysts in cultured cells instead of living animals. (2007) (2)
A novel EF-hand calcium-binding protein in the flagellum of the protozoan Tritrichomonas suis (2001) (2)
A Listeria monocytogenes-Based Vaccine Formulation Reduces Vertical Transmission and Leads to Enhanced Pup Survival in a Pregnant Neosporosis Mouse Model (2021) (2)
The Southern Redbelly Dace, Chrosomus erythrogaster erythrogaster, from the Lower Mississippi River Drainage (1957) (2)
Dual inhibition of the Echinococcus multilocularis energy metabolism (2022) (2)
Common Molecular Targets of a Quinolone Based Bumped Kinase Inhibitor in Neospora caninum and Danio rerio (2022) (2)
Dicentracin-Like from Asian sea bass Fish and Moronecidine-Like from Hippocampus Comes: Two Candidate Antimicrobial Peptides Against Leishmanina major Infection (2020) (2)
vaccines and drugs against Neospora caninum , an important apicomplexan causing abortion in cattle and other farm animals (2015) (2)
Short communication: Efficacy of albendazole in Echinococcus multilocularis-infected mice depends on the functional immunity of the host. (2020) (2)
ApiCOWplexa 2017 - 4th International Meeting on Apicomplexan Parasites in Farm Animals. (2017) (2)
A short-term treatment with BKI-1294 does not protect foetuses from sheep experimentally infected with Neospora caninum tachyzoites during pregnancy (2021) (2)
Neosporosis in Wild Canids and Other Carnivores (2017) (1)
Maca against Echinococcosis?—A Reverse Approach from Patient to In Vitro Testing (2021) (1)
The use of light- and electron microscopy for studies on the cell- and molecular biology of parasites and parasitic diseases. (2006) (1)
New Nucleic Base-Tethered Trithiolato-Bridged Dinuclear Ruthenium(II)-Arene Compounds: Synthesis and Antiparasitic Activity (2022) (1)
Echinococcus: the model cestode parasite (2021) (1)
Neosporosis in Pigs (2017) (1)
Vaccine-Linked Chemotherapy Approach: Additive Effects of Combining the Listeria monocytogenes-Based Vaccine Lm3Dx_NcSAG1 With the Bumped Kinase Inhibitor BKI-1748 Against Neospora caninum Infection in Mice (2022) (1)
Records of the lamprey Lampetra aepyptera from Alabama (1957) (1)
Response to Innes and Mattsson: Neospora caninum emerges from the shadow of Toxoplasma gondii (2007) (1)
Single- and duplex TaqMan-quantitative PCR for determining the copy numbers of integrated selection markers during site-specific mutagenesis in Toxoplasma gondii by CRISPR-Cas9 (2022) (1)
Dissection of Besnoitia besnoiti intermediate host life cycle stages: From morphology to gene expression (2022) (1)
Neosporosis in Sheep (2017) (1)
High molecular weight proteins associated with the basal body in African Trypanosomes (1995) (1)
Neosporosis in Camels and South American Camelids (2017) (1)
Wielerella bovis gen. nov., sp. nov. a member of the family Neisseriaceae associated with bovine endocarditis. (2022) (1)
Characterization of a MOB1 Homolog in the Apicomplexan Parasite Toxoplasma gondii (2021) (1)
Drugs and Drug Targets in Neospora caninum and Related Apicomplexans (2011) (1)
International meeting on apicomplexan parasites in farm animals (ApiCOWplexa) 2012. (2013) (0)
Apicomplexan Parasites: Neosporosis, Toxoplasmosis, Besnoitiosis, Theileriosis & Cryptosporidiosis (2018) (0)
INOCULATED WITH NEOSPORA CANINUM (2007) (0)
Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond Citation (2016) (0)
Neosporosis in Avian Species (2017) (0)
REDUCED CEREBRAL INFECTION OF NEOSPORA CANINUMI--INFECTED MICE AFTER VACCINATION WITH RECOMBINANT MICRONEME PROTEIN NCMIC3 AND (2003) (0)
Echinococcus multilocularis Metacestodes Diguanidino Compounds against Activities of Dicationic In Vivo and In Vitro (2013) (0)
Metacestodes multilocularis Echinococcus Vitro-Cultivated Albendazole Sulfone against In Efficacies of Albendazole Sulfoxide and (2014) (0)
Neosporosis in Humans and Primates (2017) (0)
Triggering and modulation of the host-parasite interplay by Echinococcus multilocularis: a review - CORRIGENDUM (2016) (0)
Neospora caninum experimental infection in pregnant sheep as a model for exogenous transplacental transmission for ruminant neosporosis (2013) (0)
Back Cover: Antiprotozoal Structure–Activity Relationships of Synthetic Leucinostatin Derivatives and Elucidation of their Mode of Action (Angew. Chem. Int. Ed. 28/2021) (2021) (0)
Pharmacokinetics, safety and efficacy of Bumped Kinase Inhibitor (BKI) 1553 in a pregnant sheep model of neosporosis (2017) (0)
Raw data for Figure 7C (2016) (0)
Organometallic Derivatives of Decoquinate Targeted toward Toxoplasma gondii (2022) (0)
ctivities of fenbendazole in comparison with albendazole against chinococcus multilocularis metacestodes in vitro and in a murine nfection model (2014) (0)
Maps in all Varieties — The Cytoskeleton of Trypanosoma Brucei (1989) (0)
Raw data for Video 1 (2016) (0)
Systemic and local immune responses in ewes after Neospora caninum experimental infection in the three periods of gestation (2015) (0)
Neosporosis in Water Buffaloes (Bubalus bubalis) (2017) (0)
Neosporosis in White Rhinoceros (Ceratotherium simum) (2017) (0)
Structure-funktion relationship of thiazolides, a novel class of antiparasitic drugs, investigated in intracellular protozoan parasites and larvalstage cestodes (2007) (0)
3-nitroimidazo[1,2-b]pyridazine as a novel scaffold for antiparasitics with sub-nanomolar anti-Giardia lamblia activity (2022) (0)
Effects of negative air ions (NAIs) on Leishmania major: A novel tool for treatment of zoonotic cutaneous leishmaniasis (ZCL) (2022) (0)
Neospora and neosporosis: achievement and perspectives in host and parasite cell biology (2005) (0)
A Role for Basigin in Toxoplasma gondii Infection (2022) (0)
The cytoskeleton ofTrypanosoma brucei-the beauty of simplicity (1988) (0)
Neosporosis in Goats (2017) (0)
Toxoplasma gondii Tachyzoites Complexes in Neospora caninum and Effects of Novel Ruthenium In Vitro (2014) (0)
Molecular characterization of NcMIC3 in the apicomplexan parasite Neospora caninum (2000) (0)
ApiCOWplexa 2013 – 2nd International Meeting on Apicomplexan Parasites in Farm Animals (2014) (0)
eview usceptibility versus resistance in alveolar echinococcosis ( larval nfection with Echinococcus multilocularis ) (2015) (0)
History of Neospora and Neosporosis (2017) (0)
Neosporosis in Felids (2017) (0)
Neosporosis in Cervids and Other Wild Herbivores (2017) (0)
Drug Discovery and Development for the Treatment of Echinococcosis, Caused by the TapewormsEchinococcus granulosusandEchinococcus multilocularis (2019) (0)
[Neospora caninum and neosporosis--basic science at the Institute of Parasitology and possible implications]. (2000) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Andrew Frederick Hemphill?

Andrew Frederick Hemphill is affiliated with the following schools:

University of Bern